Drug Profile
Influenza A virus vaccine H5N1 - Janssen Pharmaceuticals
Alternative Names: PanFluVacLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Crucell
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Influenza-virus-infections in Norway (IM, Injection)
- 06 Sep 2013 Isconova is now called Novavax AB
- 22 Aug 2013 Isconova has been acquired by Novavax